tiprankstipranks
Advertisement
Advertisement
Innoviva reports Q1 EPS $2.22 vs (74c) last year
PremiumThe FlyInnoviva reports Q1 EPS $2.22 vs (74c) last year
28d ago
Innoviva Shareholders Back Directors, Pay Plan and Incentives
Premium
Company Announcements
Innoviva Shareholders Back Directors, Pay Plan and Incentives
30d ago
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
Premium
Market News
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
3M ago
Innoviva price target raised to $46 from $45 at H.C. Wainwright
PremiumThe FlyInnoviva price target raised to $46 from $45 at H.C. Wainwright
6M ago
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
Premium
The Fly
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
6M ago
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
Premium
Ratings
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
6M ago
Innoviva’s Strong Q3 2025 Performance and Growth Prospects Drive Buy Rating
PremiumRatingsInnoviva’s Strong Q3 2025 Performance and Growth Prospects Drive Buy Rating
7M ago
Innoviva reports Q3 EPS $1.08 vs. 2c last year
Premium
The Fly
Innoviva reports Q3 EPS $1.08 vs. 2c last year
7M ago
Innoviva board authorizes $125M share repurchase program
Premium
The Fly
Innoviva board authorizes $125M share repurchase program
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100